International Journal of Risk & Safety in Medicine 13 (2000).
A careful review of the Multimodal Treatment Study for Attention-Deficit/Hyperactivity Disorder (the 'MTA Study') reveals serious methodological flaws that undermine its scientific validity.
"The Sedative-Like Effect of Epinephrine," Arch Gen Psych Vol 12 (1965).
Recent findings have created the need for a review of the literature concerning epinephrine-induced behavioral depression and for an evaluation of the possible mechanisms and clinical implications.
Risks and Mechanism of Action of Stimulants. NIH Consensus
Development Conference on Diagnosis and Treatment of Attention Deficit
Hyperactivity Disorder, November 16-18, 1998.
"Psychostimulants in the treatment of children diagnosed with ADHD: Risks and mechanisms of action," International Journal of Risk & Safety in Medicine 12 (1999).
"Intoxication Anosognosia: The Spellbinding Effect of Psychiatric Drugs", Ethical Human Psychology and Psychiatry, 8, 201-215, 2006.
ABSTRACT: Why do so many individuals persist in taking psychoactive substances, including psychiatric drugs, after adverse mental and behavioral effects have become severe and even disabling? The author has previously proposed the brain-disabling principle of psychiatric treatment that all somatic psychiatric treatments impair the function of the brain and mind. Intoxication anosognosia (medication spellbinding) is an expression of this druginduced mental disability. Intoxication anosognosia causes the victim to underestimate the degree of drug-induced mental impairment, to deny the harmful role that the drug plays in the person’s altered state, and in many cases compel the individual to mistakenly believe that he or she is functioning better. In the extreme, the individual displays out-of-character compulsively destructive behaviors, including violence toward self and others.
A Misdiagnosis, Anywhere. The New York Times, Oct 13, 2011.
The drugging of children for A.D.H.D. has become an epidemic. More than 5
million U.S. children, or 9.5 percent, were diagnosed with A.D.H.D. as
of 2007. About 2.8 million had received a prescription for a stimulant
medication in 2008. ...
Most psychiatric drugs can cause withdrawal reactions, sometimes including life-threatening emotional and physical withdrawal problems. In short, it is not only dangerous to start taking psychiatric drugs, it can also be dangerous to stop them. Withdrawal from psychiatric drugs should be done carefully under experienced clinical supervision. Methods for safely withdrawing from psychiatric drugs are discussed in Dr. Breggin's new book, Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients, and Their Families.